Nika Pharmaceuticals publishes investor presentation factsheet
NIKA BIOTECHNOLOGY INC
NIKA BIOTECHNOLOGY INC NIKA | 0.00 |
- Nika Pharmaceuticals published an investor presentation covering ongoing financing talks with European and US investors, with two negotiations in advanced stages.
- The materials outline plans to build a pharmaceutical factory within four months once funding is secured, with ITV-1 targeted 45 days later.
- Presentation and related podcast links: https://www.globenewswire.com/Tracker?data=k24pY9sIETzD-TVfZGaNWe1fHEOyBgjCd8r0iROE0CRAbwHAgrmX3ZqHP4F3AY0o7VwU1oNXSBbgYZAS7LWcQd9hSflJzNMwID48EUEYgWHZfBzYgh8aznOlu5qdE6dp
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nika Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606041010PRIMZONEFULLFEED9731932) on June 04, 2026, and is solely responsible for the information contained therein.
